İsmail Balık

1.7k total citations
22 papers, 535 citations indexed

About

İsmail Balık is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, İsmail Balık has authored 22 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in İsmail Balık's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). İsmail Balık is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). İsmail Balık collaborates with scholars based in Türkiye, Italy and Cambodia. İsmail Balık's co-authors include K. Aydın, Müşerref Tatman Otkun, Hakan Leblebicioğlu, Gökhan Aygün, Recep Öztürk, Akgün Yaman, Haluk Vahaboğlu, Neşe Saltoğlu, Bilgehan Aygen and Sevim Aslan Felek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and European Journal of Epidemiology.

In The Last Decade

İsmail Balık

21 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İsmail Balık Türkiye 9 212 182 167 141 103 22 535
Banu Bayraktar Türkiye 14 127 0.6× 63 0.3× 135 0.8× 156 1.1× 60 0.6× 42 428
Alexander Mischnik Germany 14 166 0.8× 57 0.3× 165 1.0× 213 1.5× 62 0.6× 34 515
Latifa Noussair France 11 209 1.0× 82 0.5× 129 0.8× 121 0.9× 72 0.7× 27 433
M.J. Rodríguez-Hernández Spain 11 198 0.9× 61 0.3× 220 1.3× 68 0.5× 59 0.6× 12 528
Cely Saad Abboud Brazil 14 281 1.3× 245 1.3× 212 1.3× 103 0.7× 53 0.5× 36 683
Haluk Güri̇z Türkiye 13 83 0.4× 45 0.2× 302 1.8× 131 0.9× 68 0.7× 36 487
Kingsley Twum-Danso Saudi Arabia 11 135 0.6× 66 0.4× 139 0.8× 56 0.4× 28 0.3× 24 387
C. Bernet France 9 148 0.7× 120 0.7× 65 0.4× 64 0.5× 51 0.5× 19 359
Antonella Eramo United States 4 418 2.0× 21 0.1× 129 0.8× 163 1.2× 80 0.8× 4 627
Yeon Joon Park South Korea 13 283 1.3× 41 0.2× 169 1.0× 110 0.8× 71 0.7× 17 471

Countries citing papers authored by İsmail Balık

Since Specialization
Citations

This map shows the geographic impact of İsmail Balık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İsmail Balık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İsmail Balık more than expected).

Fields of papers citing papers by İsmail Balık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İsmail Balık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İsmail Balık. The network helps show where İsmail Balık may publish in the future.

Co-authorship network of co-authors of İsmail Balık

This figure shows the co-authorship network connecting the top 25 collaborators of İsmail Balık. A scholar is included among the top collaborators of İsmail Balık based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İsmail Balık. İsmail Balık is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ünal, Yusuf, et al.. (2021). Pilot Study of Application of Combined Transbronchial and Intravenous Ultraviolet C (UVC) and Laser Beam Application for the Treatment of Critical COVID-19 Infection. SHILAP Revista de lepidopterología. 12(2). em00772–em00772. 1 indexed citations
2.
Tosun, Selma, İsmail Balık, Fehmı Tabak, et al.. (2019). Evaluation of Risk Factors Associated with HBsAg and Anti-HCV Seropositivity: Results of a Nationwide Population Based Epidemiological Survey Study in Turkey. SHILAP Revista de lepidopterología. 5 indexed citations
3.
Örmecı, Necati, S Malhan, İsmail Balık, et al.. (2017). Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey. Hepatology International. 11(6). 509–516. 5 indexed citations
4.
Yılmaz, Gülden, Pervin Topçuoğlu, Mehmet Gündüz, et al.. (2016). A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction. Turkish Journal of Hematology. 33(1). 41–47. 14 indexed citations
5.
Tosun, Selma, İsmail Balık, Neşe Saltoğlu, et al.. (2016). The Relationship Between the Methods of Male Circumcision Procedures Used in the Past and the Prevalence of Viral Hepatitis. Viral Hepatitis Journal. 22(1). 6–9. 1 indexed citations
6.
Örmecı, Necati, Rahmet Güner, Hasan Özkan, et al.. (2015). Tenofovir–best hope for treatment of chronic hepatitis B infection?. The Turkish Journal of Gastroenterology. 26(4). 322–327. 2 indexed citations
7.
Küçükşahin, Orhan, et al.. (2015). Sjögren’s Syndrome Developing During Hepatitis C Therapy. Klimik Dergisi/Klimik Journal. 28(2). 89–91.
8.
Örmecı, Necati, Ulus Salih Akarca, İsmail Balık, et al.. (2014). Estimation of hepatitis C costs in turkey VIA expert opinion: Delphi panel. Value in Health. 17(3). A36–A37. 2 indexed citations
9.
Aygen, Bilgehan, Oğuz Karabay, Selma Tosun, et al.. (2014). The characteristics of patients with chronic hepatitis B in Turkey.. PubMed. 11(1). 94–8. 8 indexed citations
10.
Örmecı, Necati, Füsun F. Bölükbaş, Esra Erden, et al.. (2012). Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months.. PubMed. 58(110-111). 1648–53. 19 indexed citations
11.
Aypak, Cenk, et al.. (2011). The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey. International Journal of Medical Sciences. 8(4). 339–344. 39 indexed citations
12.
Kader, Çiğdem, et al.. (2011). Infectious Etiology of Diarrhea Occurring in Neutropenic Patients. Klimik Dergisi/Klimik Journal. 24(2). 108–111. 1 indexed citations
13.
Hoşoğlu, Salih, İsmail Balık, Bilgehan Aygen, et al.. (2003). Tuberculous meningits in adults in Turkey: Epidemiology, diagnosis, clinic and laboratory. European Journal of Epidemiology. 18(4). 337–343. 29 indexed citations
14.
Cesur, Salih, et al.. (2002). [Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area].. PubMed. 36(1). 79–83. 25 indexed citations
15.
Akıncı, Esragül, et al.. (1999). Antimicrobial Susceptibility of Enterococcus Species Collected from Clinical Specimens. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Vahaboğlu, Haluk, Recep Öztürk, Gökhan Aygün, et al.. (1998). Widespread Detection of PER-1-Type Extended-Spectrum β-Lactamases among Nosocomial Acinetobacter and Pseudomonas aeruginosa Isolates in Turkey: a Nationwide Multicenter Study. Antimicrobial Agents and Chemotherapy. 42(2). 484–484. 3 indexed citations
17.
Vahaboğlu, Haluk, Recep Öztürk, Gökhan Aygün, et al.. (1997). Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrobial Agents and Chemotherapy. 41(10). 2265–2269. 198 indexed citations
18.
Balık, İsmail, et al.. (1996). Chronic Hepatitis C and Diabetes Mellitus. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Balık, İsmail, et al.. (1996). Kronik C hepatiti ve diabetes mellitus. 1(3). 167–171. 1 indexed citations
20.
Balık, İsmail, et al.. (1991). Epidemiology and clinical outcome of hepatitis D virus infection in Turkey. European Journal of Epidemiology. 7(1). 48–54. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Banu Bayraktar Breakdown of academic impact, for papers by Alexander Mischnik Breakdown of academic impact, for papers by Latifa Noussair Breakdown of academic impact, for papers by M.J. Rodríguez-Hernández Breakdown of academic impact, for papers by Cely Saad Abboud Breakdown of academic impact, for papers by Haluk Güri̇z Breakdown of academic impact, for papers by Kingsley Twum-Danso Breakdown of academic impact, for papers by C. Bernet Breakdown of academic impact, for papers by Antonella Eramo Breakdown of academic impact, for papers by Yeon Joon Park
Rankless by CCL
2026